Literature DB >> 23820077

Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis.

Prakash Saha1, Marcelo E Andia1, Bijan Modarai1, Ulrike Blume1, Julia Humphries1, Ashish S Patel1, Alkystis Phinikaridou1, Colin E Evans1, Katherine Mattock1, Steven P Grover1, Anwar Ahmad1, Oliver T Lyons1, Rizwan Q Attia1, Thomas Renné1, Sobath Premaratne1, Andrea J Wiethoff1, René M Botnar1, Tobias Schaeffter1, Matthew Waltham1, Alberto Smith1.   

Abstract

BACKGROUND: The magnetic resonance longitudinal relaxation time (T1) changes with thrombus age in humans. In this study, we investigate the possible mechanisms that give rise to the T1 signal in venous thrombi and whether changes in T1 relaxation time are informative of the susceptibility to lysis. METHODS AND
RESULTS: Venous thrombosis was induced in the vena cava of BALB/C mice, and temporal changes in T1 relaxation time correlated with thrombus composition. The mean T1 relaxation time of thrombus was shortest at 7 days following thrombus induction and returned to that of blood as the thrombus resolved. T1 relaxation time was related to thrombus methemoglobin formation and further processing. Studies in inducible nitric oxide synthase (iNOS(-/-))-deficient mice revealed that inducible nitric oxide synthase mediates oxidation of erythrocyte lysis-derived iron to paramagnetic Fe3+, which causes thrombus T1 relaxation time shortening. Studies using chemokine receptor-2-deficient mice (Ccr2(-/-)) revealed that the return of the T1 signal to that of blood is regulated by removal of Fe3+ by macrophages that accumulate in the thrombus during its resolution. Quantification of T1 relaxation time was a good predictor of successful thrombolysis with a cutoff point of <747 ms having a sensitivity and specificity to predict successful lysis of 83% and 94%, respectively.
CONCLUSIONS: The source of the T1 signal in the thrombus results from the oxidation of iron (released from the lysis of trapped erythrocytes in the thrombus) to its paramagnetic Fe3+ form. Quantification of T1 relaxation time appears to be a good predictor of the success of thrombolysis.

Entities:  

Keywords:  macrophages; magnetic resonance imaging; therapeutic thrombolysis; venous thrombosis

Mesh:

Substances:

Year:  2013        PMID: 23820077      PMCID: PMC3983557          DOI: 10.1161/CIRCULATIONAHA.113.001371

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

1.  Differentiation between hemosiderin- and ferritin-bound brain iron using nuclear magnetic resonance and magnetic resonance imaging.

Authors:  J Vymazal; D Urgosík; J W Bulte
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2000-06       Impact factor: 1.770

Review 2.  Incidence of diagnosed deep vein thrombosis in the general population: systematic review.

Authors:  F J I Fowkes; J F Price; F G R Fowkes
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-01       Impact factor: 7.069

3.  Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection.

Authors:  Joseph J Boyle; Michael Johns; Theresa Kampfer; Aivi T Nguyen; Laurence Game; Dominik J Schaer; Justin C Mason; Dorian O Haskard
Journal:  Circ Res       Date:  2011-11-03       Impact factor: 17.367

4.  Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.

Authors:  M W Mewissen; G R Seabrook; M H Meissner; J Cynamon; N Labropoulos; S H Haughton
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

5.  Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model.

Authors:  Peter K Henke; Charles G Pearce; Daria M Moaveni; Andrea J Moore; Erin M Lynch; Christopher Longo; Manu Varma; Nicholas A Dewyer; K Barry Deatrick; Gilbert R Upchurch; Thomas W Wakefield; Cory Hogaboam; Steven L Kunkel
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

6.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.

Authors:  Tone Enden; Ylva Haig; Nils-Einar Kløw; Carl-Erik Slagsvold; Leiv Sandvik; Waleed Ghanima; Geir Hafsahl; Pål Andre Holme; Lars Olaf Holmen; Anne Mette Njaastad; Gunnar Sandbæk; Per Morten Sandset
Journal:  Lancet       Date:  2011-12-13       Impact factor: 79.321

7.  Determinants of chronic venous disease after acute deep venous thrombosis.

Authors:  M H Meissner; M T Caps; B K Zierler; N Polissar; R O Bergelin; R A Manzo; D E Strandness
Journal:  J Vasc Surg       Date:  1998-11       Impact factor: 4.268

8.  Determinants of health-related quality of life during the 2 years following deep vein thrombosis.

Authors:  S R Kahn; H Shbaklo; D L Lamping; C A Holcroft; I Shrier; M J Miron; A Roussin; S Desmarais; F Joyal; J Kassis; S Solymoss; L Desjardins; M Johri; J S Ginsberg
Journal:  J Thromb Haemost       Date:  2008-06-01       Impact factor: 5.824

Review 9.  Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions.

Authors:  Prakash Saha; Julia Humphries; Bijan Modarai; Katherine Mattock; Matthew Waltham; Colin E Evans; Anwar Ahmad; Ashish S Patel; Sobath Premaratne; Oliver T A Lyons; Alberto Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

10.  Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.

Authors:  Felicitas Müller; Nicola J Mutch; Wolfdieter A Schenk; Stephanie A Smith; Lucie Esterl; Henri M Spronk; Stefan Schmidbauer; William A Gahl; James H Morrissey; Thomas Renné
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

View more
  27 in total

1.  Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-13       Impact factor: 8.311

2.  Factor XIII activity mediates red blood cell retention in venous thrombi.

Authors:  Maria M Aleman; James R Byrnes; Jian-Guo Wang; Reginald Tran; Wilbur A Lam; Jorge Di Paola; Nigel Mackman; Jay L Degen; Matthew J Flick; Alisa S Wolberg
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

Review 3.  Use of Computed Tomography and Magnetic Resonance Imaging in Central Venous Disease.

Authors:  Justinas Silickas; Stephen A Black; Alkystis Phinikaridou; Adam M Gwozdz; Alberto Smith; Prakash Saha
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

4.  Radiation Dosimetry of the Fibrin-Binding Probe ⁶⁴Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Helen Day; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  J Nucl Med       Date:  2015-05-14       Impact factor: 10.057

5.  Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.

Authors:  A S Savchenko; K Martinod; M A Seidman; S L Wong; J I Borissoff; G Piazza; P Libby; S Z Goldhaber; R N Mitchell; D D Wagner
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

Review 6.  Advanced imaging in acute and chronic deep vein thrombosis.

Authors:  Gita Yashwantrao Karande; Sandeep S Hedgire; Yadiel Sanchez; Vinit Baliyan; Vishala Mishra; Suvranu Ganguli; Anand M Prabhakar
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

7.  Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating.

Authors:  Jinjin Zhang; Hattie L Ring; Katie R Hurley; Qi Shao; Cathy S Carlson; Djaudat Idiyatullin; Navid Manuchehrabadi; P Jack Hoopes; Christy L Haynes; John C Bischof; Michael Garwood
Journal:  Magn Reson Med       Date:  2016-09-25       Impact factor: 4.668

8.  Accurate diagnosis of iliac vein thrombosis in pregnancy with magnetic resonance direct thrombus imaging (MRDTI).

Authors:  Charlotte E A Dronkers; Alexandr Srámek; Menno V Huisman; Frederikus A Klok
Journal:  BMJ Case Rep       Date:  2016-12-13

9.  18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.

Authors:  Tetsuya Hara; Jessica Truelove; Ahmed Tawakol; Gregory R Wojtkiewicz; William J Hucker; Megan H MacNabb; Anna-Liisa Brownell; Kimmo Jokivarsi; Chase W Kessinger; Michael R Jaff; Peter K Henke; Ralph Weissleder; Farouc A Jaffer
Journal:  Circulation       Date:  2014-07-28       Impact factor: 29.690

10.  Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.

Authors:  Colin E Evans; Pär-Ola Bendahl; Mattias Belting; Cristina Branco; Randall S Johnson
Journal:  Blood       Date:  2015-12-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.